ArticleMolecular & cellular proteomics : MCP2017

Prediction of Response to Sorafenib in Hepatocellular Carcinoma: A Putative Marker Panel by Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS).

Hyunsoo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.